Gainers
Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional investors at $2.48 per share.
Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares gained 108% to $3.29 after jumping 25% on Monday.
BELLUS Health Inc. (NASDAQ: BLU) shares jumped 99.5% to $14.48 after GSK announced it will acquire the company for $14.75 per share in cash, representing an approximate total equity value of $2 billion.
SAB Biotherapeutics, Inc. (NASDAQ: SABS) rose 79% to $1.38. The FDA granted Breakthrough Therapy Designation (BTD) to SAB Biotherapeutics SAB-176, an investigational therapy for post-exposure prophylaxis for Type A and Type B influenza illness in high-risk patients, including antiviral resistant strains.
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) gained 57.7% to $4.73 after the company reported key first quarter milestone achievements for drug discovery.
Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 55% to $1.84.
Super League Gaming, Inc. (NASDAQ: SLGG) surged 39% to $0.5949 after the company and LandVault announced a strategic partnership to provide brands with scalable solutions to bridge the gap between Web2 and Web3.
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) rose 38.3% to $8.13. Phio presented preclinical data showing synergy-enhanced in vivo anti-tumor efficacy of PD-1/CTLA-4 dual-targeting INTASYL.
Gamida Cell Ltd. (NASDAQ: GMDA) climbed 33% to $1.49 after the U.S. Food and Drug Administration approved Gamida Cell’s allogeneic cell therapy, Omisirge® (omidubicel-onlv).
Toro Corp. (NASDAQ: TORO) gained 29.4% to $4.2344.
YS Biopharma Co., Ltd. (NASDAQ: YS) gained 26% to $1.99 after the company reported preliminary total revenue of $103 million, representing a year-over-year growth of 30%.
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) shares gained 25% to $4.8212.
Trevi Therapeutics, Inc. (NASDAQ:
Benzinga
